Global Healthcare Study on Psoriasis
NCT07634016 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9600
Last updated 2026-06-08
Summary
The Global Healthcare Study on Psoriasis (GHSP) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with psoriasis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Conditions
- Psoriasis (PsO)
Sponsors & Collaborators
-
University of Zurich
collaborator OTHER -
University Hospital, Zürich
collaborator OTHER -
Julia Tatjana Maul
lead OTHER
Principal Investigators
-
Julia-Tatjana Maul, Prof. Dr. med. · University of Zurich
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
NCT07532226 ·Status: RECRUITING
-
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
NCT03818035 ·Status: COMPLETED ·Phase: PHASE3
-
Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries
NCT02668341 ·Status: UNKNOWN
-
Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index
NCT06579976 ·Status: NOT_YET_RECRUITING
-
Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
NCT00162253 ·Status: TERMINATED ·Phase: PHASE2
-
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
NCT03553433 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
NCT07582783 ·Status: RECRUITING
-
A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis
NCT02382081 ·Status: COMPLETED ·Phase: NA
-
PsoBest - The German Psoriasis Registry
NCT01848028 ·Status: RECRUITING
-
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
NCT02207231 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
NCT03998683 ·Status: COMPLETED ·Phase: PHASE3
-
The Disease Severity In Patients With Psoriasis
NCT05943405 ·Status: COMPLETED
-
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
NCT02203032 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
NCT07532486 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
NCT05730725 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
NCT06039189 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis
NCT02595970 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
NCT05125679 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy
NCT03796858 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
NCT07220824 ·Status: RECRUITING
-
A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
NCT04826536 ·Status: COMPLETED
-
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
NCT06231381 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
NCT07449234 ·Status: TERMINATED
-
The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance
NCT06165887 ·Status: NOT_YET_RECRUITING
-
Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures
NCT07495657 ·Status: NOT_YET_RECRUITING